Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.31 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6887027 | 0.79 | — | — | |
| SCHEMBL28022279 | 0.76 | — | — | |
| SCHEMBL1982143 | 0.74 | — | — | |
| SCHEMBL9159764 | 0.74 | — | — | |
| SCHEMBL4024375 | 0.74 | — | — | |
| SCHEMBL8270697 | 0.74 | — | — | |
| SCHEMBL12805217 | 0.74 | — | — | |
| SCHEMBL16123466 | 0.74 | — | — | |
| SCHEMBL21645064 | 0.74 | — | — | |
| SCHEMBL20216218 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106433135-A | Curable rubber composition and curable rubber | 黄品超 | 2017-02-22 | — | — | CN | claimed |
| EP-4704916-A1 | MODIFIED ANTIBODIES, ANTIBODY FRAGMENTS THEREOF, AND ANTIBODY-DRUG CONJUGATES | Innovent Biologics (Suzhou) Co., Ltd. (CN) | 2026-03-11 | — | — | EP | disclosed |
| EP-4648799-A1 | LIGAND-DRUG CONJUGATES | Sun Pharma Advanced Research Company Ltd (IN) | 2025-11-19 | — | — | EP | disclosed |
| CN-120058585-A | Dimercapto conjugate of active allyl alcohol acetate, and preparation method and application thereof | 南京工业大学 | 2025-05-30 | — | — | CN | disclosed |
| WO-2025103474-A1 | DOUBLE-TOXIN ANTIBODY-DRUG CONJUGATE AND USE THEREOF | 成都康弘生物科技有限公司 | 2025-05-22 | — | — | WO | disclosed |
| CN-120019819-A | Double toxin antibody drug conjugate and application thereof | 成都康弘生物科技有限公司 | 2025-05-20 | — | — | CN | disclosed |
| CN-119455000-A | Triazine compound, conjugate thereof, preparation method and application | 四川科伦博泰生物医药股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119431181-A | Di-ene linker, linker-drug conjugate, antibody-conjugated drug and uses thereof | 泰诚思(上海)生物医药有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119318715-A | Anti-PD-L1 and Anti-HER2 diabody oriented nano-drug system and preparation method and application thereof | 江苏大学 | 2025-01-17 | — | — | CN | disclosed |
| EP-4486775-A2 | THERAPEUTIC ANTIBODIES | Cambridge Enterprise Limited (GB) | 2025-01-08 | — | — | EP | disclosed |
| WO-2023166318-A2 | THERAPEUTIC ANTIBODIES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2023-09-07 | — | — | WO | disclosed |
| WO-2022223783-A9 | THIOL-CONJUGATION WITH UNSATURATED PHOSPHORUS(V) COMPOUNDS | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 2023-03-02 | — | — | WO | disclosed |
| CN-115666653-A | Antibody-drug conjugates | 斯皮雷亚有限公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-106433135-A | Curable rubber composition and curable rubber | 黄品超 | 2017-02-22 | — | — | CN | disclosed |
| US-20130287700-A1 | COMPOUNDS FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISORDERS ON THE OLFACTORY EPITHELIUM | KLINIKUM DARMSTADT GMBH (DE) | 2013-10-31 | — | — | US | disclosed |
| EP-2619590-A2 | COMPOUNDS FOR DIAGNOSING NEURODEGENERATIVE DISEASES AT THE RETINA | Technische Universität Darmstadt (DE) | 2013-07-31 | — | — | EP | disclosed |
| EP-2619591-A2 | COMPOUNDS FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISORDERS ON THE OLFACTORY EPITHELIUM | Technische Universität Darmstadt (DE) | 2013-07-31 | — | — | EP | disclosed |
| WO-2012041292-A2 | COMPOUNDS FOR DIAGNOSING NEURODEGENERATIVE DISEASES AT THE RETINA | KLINIKUM DARMSTADT GMBH (DE) | 2012-04-05 | — | — | WO | disclosed |
| WO-2012037928-A2 | COMPOUNDS FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISORDERS ON THE OLFACTORY EPITHELIUM | KLINIKUM DARMSTADT GMBH (DE) | 2012-03-29 | — | — | WO | disclosed |
| US-5439950-A | Intraocular lenses | KABI PHARMACIA OPHTHALMICS, INC. (US) | 1995-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130287700-A1 | COMPOUNDS FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISORDERS ON THE OLFACTORY EPITHELIUM | SNCA, MAPT, TARDBP | HDAC8 4540/4885GRM4 1348/4885S1PR4 3344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.